Galectin Therapeutics Inc. (GALT)
NASDAQ: GALT · Real-Time Price · USD
2.190
+0.020 (0.92%)
At close: May 18, 2026, 4:00 PM EDT
2.130
-0.060 (-2.74%)
After-hours: May 18, 2026, 5:36 PM EDT
Galectin Therapeutics Employees
Galectin Therapeutics had 9 employees as of December 31, 2025. The number of employees decreased by 6 or -40.00% compared to the previous year.
Employees
9
Change (1Y)
-6
Growth (1Y)
-40.00%
Revenue / Employee
n/a
Profits / Employee
-$2,931,556
Market Cap
144.16M
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 9 | -6 | -40.00% |
| Dec 31, 2024 | 15 | 1 | 7.14% |
| Dec 31, 2023 | 14 | 2 | 16.67% |
| Dec 31, 2022 | 12 | 3 | 33.33% |
| Dec 31, 2021 | 9 | 3 | 50.00% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Protalix BioTherapeutics | 226 |
| Molecular Partners AG | 134 |
| Alps Group | 93 |
| Korro Bio | 49 |
| Spero Therapeutics | 25 |
| TuHURA Biosciences | 22 |
| Black Diamond Therapeutics | 21 |
| Spruce Biosciences | 8 |
GALT News
- 3 days ago - Galectin Therapeutics Reports March 31, 2026 Financial Results and Provides Business Update - GlobeNewsWire
- 7 days ago - Galectin Therapeutics publishes NAVIGATE Phase 2b trial results - TheFly
- 7 days ago - Galectin Therapeutics Announces Publication of NAVIGATE Phase 2b Trial Results for Belapectin in the Journal of Hepatology - GlobeNewsWire
- 21 days ago - Galectin Therapeutics, Inc. Investigated by the Portnoy Law Firm - GlobeNewsWire
- 6 weeks ago - Galectin Therapeutics files $200M mixed securities shelf - TheFly
- 2 months ago - Galectin Therapeutics appoints Henry Brem to board of directors - TheFly
- 2 months ago - Galectin Therapeutics Transcript: KOL event - Transcripts
- 5 months ago - Galectin Therapeutics provides regulatory update following FDA written response - TheFly